Protopic Related Published Studies
Well-designed clinical trials related to Protopic (Tacrolimus Topical)
Pimecrolimus vs. tacrolimus for the topical treatment of unresponsive oral
erosive lichen planus: a 8 week randomized double-blind controlled study. [2014]
Topical tacrolimus significantly promotes repigmentation in idiopathic guttate
hypomelanosis: a double-blind, randomized, placebo-controlled study. [2013]
A comparative study in efficacy and safety of 0.1% tacrolimus and 0.05%
clobetasol propionate ointment in discoid lupus erythematosus by modified
cutaneous lupus erythematosus disease area and severity index. [2012]
Single-blind, randomized controlled trial evaluating the treatment of facial seborrheic dermatitis with hydrocortisone 1% ointment compared with tacrolimus 0.1% ointment in adults. [2011.11.17]
A double-blind, randomized, placebo-controlled trial of topical tacrolimus 0.1% vs. clobetasol propionate 0.05% in childhood vitiligo. [2011.09]
Efficacy of tacrolimus 0.1% ointment in cutaneous lupus erythematosus: a multicenter, randomized, double-blind, vehicle-controlled trial. [2011.07]
Effects of topical corticosteroid and tacrolimus on ceramides and irritancy to sodium lauryl sulphate in healthy skin. [2011.05]
Effects of tacrolimus ointment on Toll-like receptors in atopic dermatitis. [2011.04]
Applicability of an exaggerated forearm wash test for efficacy testing of two corticosteroids, tacrolimus and glycerol, in topical formulations against skin irritation induced by two different irritants. [2011.02]
An investigation comparing the efficacy of topical ocular application of tacrolimus and cyclosporine in dogs. [2011]
Efficacy of tacrolimus 0.1% ointment in cutaneous lupus erythematosus: a
multicenter, randomized, double-blind, vehicle-controlled trial. [2011]
A double-blind, randomized, placebo-controlled trial of topical tacrolimus 0·1%
vs. clobetasol propionate 0·05% in childhood vitiligo. [2011]
Evaluation of methylprednisolone aceponate, tacrolimus and combination thereof in the psoriasis plaque test using sum score, 20-MHz-ultrasonography and optical coherence tomography. [2010.12]
Twice-weekly treatment with tacrolimus 0.03% ointment in children with atopic dermatitis: clinical efficacy and economic impact over 12 months. [2010.09]
Quality of life and health-related utility analysis of adults with moderate and severe atopic dermatitis treated with tacrolimus ointment vs. topical corticosteroids. [2010.06]
A randomized, placebo-controlled clinical trial of tacrolimus ophthalmic suspension 0.1% in severe allergic conjunctivitis. [2010.04]
One-year treatment with 0.1% tacrolimus ointment versus a corticosteroid regimen in adults with moderate to severe atopic dermatitis: A randomized, double-blind, comparative trial. [2010.03]
Time-kinetic study of repigmentation in vitiligo patients by tacrolimus or pimecrolimus. [2010.03]
Safety and efficacy of tacrolimus ointment versus pimecrolimus cream in the treatment of patients with atopic dermatitis previously treated with corticosteroids. [2010]
A randomized, placebo-controlled clinical trial of tacrolimus ophthalmic
suspension 0.1% in severe allergic conjunctivitis. [2010]
Health-related utility among adults with atopic dermatitis treated with 0.1% tacrolimus ointment as maintenance therapy over the long term: findings from the Protopic CONTROL study. [2009.12]
An open randomized study to compare narrow band UVB, topical pimecrolimus and topical tacrolimus in the treatment of vitiligo. [2009.11]
Response of vitiligo to once- vs. twice-daily topical tacrolimus: a controlled prospective, randomized, observer-blinded trial. [2009.08]
The pharmacokinetics of tacrolimus after first and repeated dosing with 0.03% ointment in infants with atopic dermatitis. [2009.04]
Efficacy of topical tacrolimus 0.1% in active plaque morphea: randomized, double-blind, emollient-controlled pilot study. [2009]
Three times weekly tacrolimus ointment reduces relapse in stabilized atopic dermatitis: a new paradigm for use. [2008.12]
Proactive disease management with 0.03% tacrolimus ointment for children with atopic dermatitis: results of a randomized, multicentre, comparative study. [2008.12]
Topical tacrolimus 0.1% improves symptoms of hand dermatitis in patients treated with a prednisone taper. [2008.07]
Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment. [2008.07]
A single-center open-label long-term comparison of tacrolimus ointment and topical corticosteroids for treatment of atopic dermatitis. [2008.07]
Topical treatment of mild to moderate plaque psoriasis with 0.3% tacrolimus gel and 0.5% tacrolimus cream: the effect on SUM score, epidermal proliferation, keratinization, T-cell subsets and HLA-DR expression. [2008.04]
A comparative treatment study of topical tacrolimus and clobetasol in oral lichen planus. [2008.02]
Comparison of cutaneous tolerance and efficacy of calcitriol 3 mug g(-1) ointment and tacrolimus 0.3 mg g(-1) ointment in chronic plaque psoriasis involving facial or genitofemoral areas: a double-blind, randomized controlled trial. [2007.11]
Topical tacrolimus in the treatment of perianal Crohn's disease: Exploratory randomized controlled trial. [2007.03]
The comparative effects of tacrolimus and hydrocortisone in adult atopic dermatitis: an immunohistochemical study. [2007.02]
Staphylococcus colonization in atopic dermatitis treated with fluticasone or tacrolimus with or without antibiotics. [2007.01]
Topical tacrolimus in the treatment of perianal Crohn's disease: Exploratory randomized controlled trial. [2006.12.19]
Tacrolimus powder in Orabase 0.1% for the treatment of oral lichen planus and oral lichenoid lesions: an open clinical trial. [2006.12]
Tacrolimus ointment in nickel sulphate-induced steroid-resistant allergic contact dermatitis. [2006.11]
Tacrolimus ointment does not affect the immediate response to vaccination, the generation of immune memory, or humoral and cell-mediated immunity in children. [2006.11]
A comparison of treatment of oral lichen planus with topical tacrolimus and triamcinolone acetonide ointment. [2006]
0.3% Tacrolimus gel and 0.5% Tacrolimus cream show efficacy in mild to moderate plaque psoriasis: Results of a randomized, open-label, observer-blinded study. [2006]
Tacrolimus ointment 0.03% is safe and effective for the treatment of mild to moderate atopic dermatitis in pediatric patients: results from a randomized, double-blind, vehicle-controlled study. [2005.09]
Non-melanoma skin cancer in patients with atopic dermatitis treated with topical tacrolimus. [2005.08]
Effect of topical 0.02% tacrolimus aqueous suspension on tear production in dogs with keratoconjunctivitis sicca. [2005.07]
A multicentre, randomized, double-blind, controlled study of long-term treatment with 0.1% tacrolimus ointment in adults with moderate to severe atopic dermatitis. [2005.06]
Lack of efficacy of tacrolimus ointment 0.1% for treatment of hemodialysis-related pruritus: a randomized, double-blind, vehicle-controlled study. [2005.03]
Treatment of localized lesions of canine atopic dermatitis with tacrolimus ointment: a blinded randomized controlled trial. [2005.02]
Topical tacrolimus ointment combined with 6% salicylic acid gel for plaque psoriasis treatment. [2005.01]
Tacrolimus ointment is effective for facial and intertriginous psoriasis. [2004.11]
Investigation on the clinical efficacy and safety of 0.1% tacrolimus ointment (Protopic) in canine atopic dermatitis: a randomized, double-blinded, placebo-controlled, cross-over study. [2004.10]
Topical tacrolimus and the 308-nm excimer laser: a synergistic combination for the treatment of vitiligo. [2004.09]
Investigation on the effects of topical therapy with 0.1% tacrolimus ointment (Protopic) on intradermal skin test reactivity in atopic dogs. [2004.08]
Comparing tacrolimus ointment and oral cyclosporine in adult patients affected by atopic dermatitis: a randomized study. [2004.04]
0.03% Tacrolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis: results of a randomized double-blind controlled trial. [2004.03]
Combined excimer laser and topical tacrolimus for the treatment of vitiligo: a pilot study. [2004.02]
Topical tacrolimus 0.1% ointment (protopic) reverses nickel contact dermatitis elicited by allergen challenge to a similar degree to mometasone furoate 0.1% with greater suppression of late erythema. [2003.10]
Tacrolimus ointment 0.1% in the treatment of nickel-induced allergic contact dermatitis. [2003.09]
Clocortolone pivalate cream 0.1% used concomitantly with tacrolimus ointment 0.1% in atopic dermatitis. [2003.08]
Safe treatment of head/neck AD with tacrolimus ointment. [2003.06]
A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo. [2003.05]
Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone butyrate ointment in adult patients with atopic dermatitis. [2002.03]
Topical tacrolimus (FK506) and mometasone furoate in treatment of dyshidrotic palmar eczema: a randomized, observer-blinded trial. [2002.01]
Comparison of the effects of daily applications between topical corticosteroid and tacrolimus ointments on normal skin: evaluation with noninvasive methods. [2002]
Topical tacrolimus (FK506) leads to profound phenotypic and functional alterations of epidermal antigen-presenting dendritic cells in atopic dermatitis. [2001.03]
Tacrolimus ointment improves psoriasis in a microplaque assay. [1999.07]
A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in children. Pediatric Tacrolimus Study Group. [1998.10]
Topical tacrolimus is not effective in chronic plaque psoriasis. A pilot study. [1998.09]
A short-term trial of tacrolimus ointment for atopic dermatitis. European Tacrolimus Multicenter Atopic Dermatitis Study Group. [1997.09.18]
Well-designed clinical trials possibly related to Protopic (Tacrolimus Topical)
In vivo vitiligo induction and therapy model: double-blind, randomized clinical
trial. [2012]
Erosive pustular dermatosis of the scalp: A review with a focus on dapsone therapy. [2011.11.08]
Bilateral comparison study of pimecrolimus cream 1% and a ceramide-hyaluronic acid emollient foam in the treatment of patients with atopic dermatitis. [2011.06]
A double-blind, randomized controlled trial of clobetasol versus pimecrolimus in patients with vulvar lichen sclerosus. [2011.06]
Beneficial effect of a diet containing heat-killed Lactobacillus paracasei K71 on adult type atopic dermatitis. [2011.02]
Clinical and cytological effects of pimecrolimus cream 1% after resolution of active atopic dermatitis lesions by topical corticosteroids: a randomized controlled trial. [2011.02]
Efficacy and tolerability of proactive treatment with topical corticosteroids and calcineurin inhibitors for atopic eczema: systematic review and meta-analysis of randomized controlled trials. [2011.02]
A bilateral comparison study of pimecrolimus cream 1% and a topical medical
device cream in the treatment of patients with atopic dermatitis. [2011]
A double-blind, randomized controlled trial of clobetasol versus pimecrolimus in
patients with vulvar lichen sclerosus. [2011]
Beneficial effect of a diet containing heat-killed Lactobacillus paracasei K71 on
adult type atopic dermatitis. [2011]
Pimecrolimus 1% cream in the treatment of cutaneous lesions of pemphigus vulgaris: a double-blind, placebo-controlled clinical trial. [2010.06]
Addition of pimecrolimus cream 1% to a topical corticosteroid treatment regimen in paediatric patients with severe atopic dermatitis: a randomized, double-blind trial. [2010.05]
A comparison of metronidazole 1% cream and pimecrolimus 1% cream in the treatment of patients with papulopustular rosacea: a randomized open-label clinical trial. [2010.04]
Topical treatment and combination approaches for vitiligo: new insights, new developments. [2010.02]
New treatment strategy and assessment questionnaire for external auditory canal pruritus: topical pimecrolimus therapy and Modified Itch Severity Scale. [2010.02]
The safety and efficacy of pimecrolimus, 1%, cream for the treatment of Netherton syndrome: results from an exploratory study. [2010.01]
Pimecrolimus 1% cream in the treatment of cutaneous lesions of pemphigus
vulgaris: a double-blind, placebo-controlled clinical trial. [2010]
A prospective randomized trial of topical pimecrolimus for cetuximab-associated acnelike eruption. [2009.10]
Pimecrolimus 1% cream versus betamethasone 17-valerate 0.1% cream in the treatment of facial discoid lupus erythematosus: a double-blind, randomized pilot study. [2009.10]
Twice-daily versus once-daily applications of pimecrolimus cream 1% for the prevention of disease relapse in pediatric patients with atopic dermatitis. [2009.09]
Effects of pimecrolimus cream 1% in the treatment of patients with atopic dermatitis who demonstrate a clinical insensitivity to topical corticosteroids: a randomized, multicentre vehicle-controlled trial. [2009.08]
Combination of 308-nm excimer laser with topical pimecrolimus for the treatment of childhood vitiligo. [2009.05]
The efficacy of pimecrolimus 1% cream combined with microdermabrasion in the treatment of nonsegmental childhood vitiligo: a randomized placebo-controlled study. [2009.05]
Clinical efficacies of topical agents for the treatment of seborrheic dermatitis of the scalp: a comparative study. [2009.03]
Comparison of clinical efficacy of topical pimecrolimus with betamethasone in chronic skin lesions due to sulfur mustard exposure: a randomized, investigator-blind study. [2009.02]
The treatment of facial atopic dermatitis in children who are intolerant of, or dependent on, topical corticosteroids: a randomized, controlled clinical trial. [2009.02]
Skin physiological parameters confirm the therapeutic efficacy of pimecrolimus cream 1% in patients with mild-to-moderate atopic dermatitis. [2009.01]
Clinical evaluation of pimecrolimus eye drops for treatment of canine keratoconjunctivitis sicca: a comparison with cyclosporine A. [2009.01]
An open, randomized, prospective, comparative study of topical pimecrolimus 1% cream and topical ketoconazole 2% cream in the treatment of seborrheic dermatitis. [2009]
The efficacy of pimecrolimus 1% cream plus narrow-band ultraviolet B in the treatment of vitiligo: a double-blind, placebo-controlled clinical trial. [2009]
Pimecrolimus 1% cream, methylprednisolone aceponate 0.1% cream and metronidazole 0.75% gel in the treatment of seborrhoeic dermatitis: a randomized clinical study. [2009]
Effectiveness and safety of a prevention-of-flare-progression strategy with pimecrolimus cream 1% in the management of paediatric atopic dermatitis. [2008.11]
|